MedRisk acquires Medical Diagnostic Associates Management

MedRisk, Inc., the nation's leading provider of physical medicine management to the workers' compensation industry, has acquired Medical Diagnostic Associates Management, Inc. (MDIA) based in Calabasas, Calif., and its access to a national diagnostic imaging network.

The acquisition is expected to enhance both companies' ability to manage medical costs and treatment strategies for improved patient care. Among the benefits to injured workers and payers are swift and smooth access to imaging, faster diagnoses and the ability to start physical medicine treatment sooner. The acquisition is supported by a marketplace demand for an alternate national imaging network.

Similar corporate philosophies built on clinical expertise and customer service brought the companies together. "We are delighted to work with a company that shares our values," said Shelley Boyce, CEO of MedRisk, noting that MedRisk continuously analyzes treatment protocols and compares evidence-based guidelines against its 20 years of claims data to facilitate quality care and manage costs. "MDIA has an impressive physician-driven, outcomes-based approach to diagnostic imaging," she said.

"MedRisk and MDIA both use advanced technology and on-site clinical expertise to contain costs and improve patient care. Unlike its competitors, MDIA has access to on-site, board-certified radiologists to oversee patient referrals and ensure that the appropriate examination, using the appropriate modality is performed. Studies can be accessed online 24/7 and those radiologists are available to discuss examination results with referring physicians and payers," said MDIA's Founder Ronald J. Friedman, M.D. "All of us at MDIA are looking forward to our new relationship with MedRisk."

Source:

MedRisk Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sex-specific mitochondrial marker deficiencies linked to early cognitive dysfunction in Alzheimer’s disease